46 related articles for article (PubMed ID: 8548944)
1. Kisspeptin Overcomes GnRH Neuronal Suppression Secondary to Hyperprolactinemia in Humans.
Hoskova K; Kayton Bryant N; Chen ME; Nachtigall LB; Lippincott MF; Balasubramanian R; Seminara SB
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3515-e3525. PubMed ID: 35323937
[TBL] [Abstract][Full Text] [Related]
2. Effective stimulation of daily LH secretion by the combined treatment with melatonin and naloxone in luteal-phase ewes.
Misztal T; Romanowicz K
Acta Neurobiol Exp (Wars); 2005; 65(1):1-9. PubMed ID: 15794026
[TBL] [Abstract][Full Text] [Related]
3. Free-living competitive racewalkers and runners with energy availability estimates of <35 kcal·kg fat-free mass
Castellanos-Mendoza MC; Galloway SDR; Witard OC
Front Sports Act Living; 2023; 5():1279534. PubMed ID: 38046932
[TBL] [Abstract][Full Text] [Related]
4. Are menstrual disturbances associated with an energy availability threshold? A critical review of the evidence.
Salamunes ACC; Williams NI; De Souza MJ
Appl Physiol Nutr Metab; 2024 May; 49(5):584-598. PubMed ID: 38194640
[TBL] [Abstract][Full Text] [Related]
5. The effects of opioid blockade and GnRH administration upon luteinizing hormone secretion in patients with anorexia nervosa during the stages of weight loss and weight recovery.
García-Rubí E; Vazquez-Alemán D; Mendez JP; Salinas JL; Garza-Flores J; Ponce-de-León S; Perez-Palacios G; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1992 Dec; 37(6):520-8. PubMed ID: 1286522
[TBL] [Abstract][Full Text] [Related]
6. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
Tay CC; Glasier AF; Illingworth PJ; Baird DT
Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
[TBL] [Abstract][Full Text] [Related]
7. Opioidergic regulation of LH pulsatility in women with polycystic ovary syndrome.
Berga SL; Yen SS
Clin Endocrinol (Oxf); 1989 Feb; 30(2):177-84. PubMed ID: 2532984
[TBL] [Abstract][Full Text] [Related]
8. Naloxone increases the frequency of pulsatile luteinizing hormone secretion in women with hyperprolactinemia.
Cook CB; Nippoldt TB; Kletter GB; Kelch RP; Marshall JC
J Clin Endocrinol Metab; 1991 Nov; 73(5):1099-105. PubMed ID: 1939525
[TBL] [Abstract][Full Text] [Related]
9. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
[TBL] [Abstract][Full Text] [Related]
10. Evidence for an altered luteinizing hormone sensitivity to naloxone in pathological hyperprolactinaemia.
Larrea F; Sandoval JL; Salinas E; Franco-Rodriguez VA; Méndez I; Ulloa-Aguirre A
Clin Endocrinol (Oxf); 1995 Nov; 43(5):591-600. PubMed ID: 8548944
[TBL] [Abstract][Full Text] [Related]
11. The role of changing pulse frequency in the regulation of ovulation.
Marshall JC; Griffin ML
Hum Reprod; 1993 Nov; 8 Suppl 2():57-61. PubMed ID: 8276970
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic dysfunction.
Marshall JC; Eagleson CA; McCartney CR
Mol Cell Endocrinol; 2001 Oct; 183(1-2):29-32. PubMed ID: 11604221
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
